Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Baxter
Colorcon
Queensland Health
Healthtrust
Chubb
Boehringer Ingelheim
Moodys

Generated: May 26, 2018

DrugPatentWatch Database Preview

PAXIPAM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Paxipam, and when can generic versions of Paxipam launch?

Paxipam is a drug marketed by Schering and is included in one NDA.

The generic ingredient in PAXIPAM is halazepam. There are two drug master file entries for this compound. Additional details are available on the halazepam profile page.
Summary for PAXIPAM
Drug patent expirations by year for PAXIPAM
Synonyms for PAXIPAM
23092-17-3
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-
320YC168LF
5-24-04-00303 (Beilstein Handbook Reference)
7-Chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one
7-Chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one
7=Chlor-5-phenyl-1-(2,2,2-trifluorethyl)-1H-1,4-benzodiazepin-2(3H)-on
9-chloro- 6-phenyl- 2-(2,2,2-trifluoroethyl)- 2,5-diazabicyclo[5.4.0] undeca- 5,8,10,12-tetraen -3-one
AC1L1M12
AC1Q4K6Z
Alapryl
Alapryl (TN)
AN-6362
API0003760
BDBM50408018
BRN 0898553
C17H12ClF3N2O
CHEBI:5603
CHEMBL970
D00338
D0Z9VB
DB00801
DEA No. 2762
DTXSID5023118
EINECS 245-425-4
FT-0669095
GTPL7195
Halazepam
Halazepam (USAN/INN)
Halazepam [USAN:BAN:INN]
Halazepam [USAN:USP:INN:BAN]
Halazepamum
Halazepamum [INN-Latin]
Halezepam
HE004910
HE327052
LS-34273
Pacinone
Pacinone (TN)
Paxipam (TN)
Sch 12041
Sch-12041
SCHEMBL78995
Schering 12041
UNII-320YC168LF
WYCLKVQLVUQKNZ-UHFFFAOYSA-N
ZINC537811

US Patents and Regulatory Information for PAXIPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering PAXIPAM halazepam TABLET;ORAL 017736-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering PAXIPAM halazepam TABLET;ORAL 017736-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Johnson and Johnson
Boehringer Ingelheim
Cerilliant
Medtronic
Farmers Insurance
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.